Related Experiment Video
Updated: Oct 19, 2025

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Published on: January 5, 2016
Exosome-mediated stable epigenetic repression of HIV-1
Surya Shrivastava1, Roslyn M Ray1, Leo Holguin1
1Center for Gene Therapy, City of Hope-Beckman Research Institute, Duarte, CA, USA.
Researchers developed a novel exosome therapy to epigenetically repress Human Immunodeficiency Virus (HIV-1). This "block and lock" approach uses engineered exosomes to deliver a repressor, offering a safer, long-term strategy against persistent HIV-1 infection.
Area of Science:
- Epigenetics
- Virology
- Nanomedicine
Background:
- Human Immunodeficiency Virus (HIV-1) establishes persistent latent infections, challenging current treatments.
- Combination antiretroviral therapy (cART) for HIV-1 has limitations, including side effects and drug resistance.
- A safer, in vivo therapeutic strategy is needed to achieve stable, long-term repression of HIV-1.
Purpose of the Study:
- To develop a novel therapeutic strategy for stable epigenetic repression of HIV-1.
- To engineer exosomes for in vivo delivery of an HIV-1 repressor.
- To investigate the efficacy of exosome-mediated epigenetic silencing of HIV-1.
Main Methods:
- Development of a Zinc Finger Protein (ZFP-362) fused to DNA methyltransferase 3A to target and repress the HIV-1 promoter.
- Engineering cells to produce exosomes containing RNA encoding the HIV-1 repressor.
- Administration of anti-HIV-1 exosomes to humanized NSG mouse models.
Main Results:
- Engineered exosomes successfully delivered the HIV-1 repressor protein.
- Exosome-mediated delivery resulted in suppression of HIV-1 expression.
- Epigenetic repression, specifically DNA methylation of HIV-1, was identified as the mechanism of suppression.
Conclusions:
- Exosome-mediated delivery of therapeutic cargo offers a promising platform for systemic treatment of HIV-1.
- This approach achieves stable, long-term epigenetic repression of HIV-1, offering a potential "block and lock" strategy.
- The findings pave the way for developing safer, more effective therapies for persistent HIV-1 infections.
Related Concept Videos
Size and Structure of Viral Genomes
Inheritance of Chromatin Structures
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Viruses with RNA Genomes
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

